Abstract
In this review article we present the evidence to date supporting the role of the calcium-sensing receptor (CaSR) as a key, pluripotential molecular trigger for asthma and speculate on the likely benefits of topical therapy of asthma with negative allosteric modulators of the CaSR: calcilytics.
Cite
CITATION STYLE
Riccardi, D., Ward, J. P. T., Yarova, P. L., Janssen, L. J., Lee, T. H., Ying, S., & Corrigan, C. J. (2022, August 1). Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: The beginning of a new era? European Respiratory Journal. European Respiratory Society. https://doi.org/10.1183/13993003.02103-2021
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
